<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03677778</url>
  </required_header>
  <id_info>
    <org_study_id>46830</org_study_id>
    <nct_id>NCT03677778</nct_id>
  </id_info>
  <brief_title>Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade</brief_title>
  <official_title>Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the most frequently performed peripheral nerve blocks (the injection of local&#xD;
      anesthetic near nerves to block sensation/ movement to a specific part of the body) is the&#xD;
      interscalene brachial plexus block for upper extremity surgeries. This type of block can&#xD;
      unmask underlying respiratory issues such as shortness of breath due to a well-known and&#xD;
      typically insignificant side effect of temporary diaphragmatic paralysis.&#xD;
&#xD;
      The nerve block may be able to use saline solution to wash out the local anesthetic and&#xD;
      potentially reverse this respiratory side effect. Specifically, the goal of this study is to&#xD;
      determine if the injection of saline through the nerve block catheter reverses blockade of&#xD;
      the phrenic nerve supplying the diaphragm, without affecting the ability of the nerve block&#xD;
      to provide pain control after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 22, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragmatic excursion</measure>
    <time_frame>15 minutes (5 minutes each for a total of 3 assessments)</time_frame>
    <description>Diaphragmatic excursion will be assessed via ultrasound before nerve block is placed, after surgery, and while receiving either the placebo or treatment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain scores</measure>
    <time_frame>3 minutes (1 minute each for a total of 3 assessments)</time_frame>
    <description>Pain scores will be assessed before nerve block is placed, after surgery, while receiving either the placebo or treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brachial plexus sensory and motor exam</measure>
    <time_frame>6 minutes (2 minutes each for a total of 3 assessments)</time_frame>
    <description>Secondary end points include brachial plexus sensory and motor exam changes, which will be assessed before nerve block is placed, after surgery, and while receiving either the placebo or treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incentive Spirometry Volume</measure>
    <time_frame>3 minutes (1 minute each for a total of 3 assessments)</time_frame>
    <description>Incentive Spirometry volume will be collected before nerve block is placed, after surgery, and while receiving either the placebo or treatment. An incentive spirometer is a non-invasive device that measures how deeply you can inhale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anesthesia, Local</condition>
  <condition>Phrenic Nerve Paralysis</condition>
  <condition>Upper Extremity Injury</condition>
  <condition>Phrenic Nerve Palsy on the Left</condition>
  <condition>Phrenic Nerve Palsy on the Right</condition>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This control group will have no normal saline injected into their nerve catheter (no intervention). This group will have the following measured/ assessed after 10 minutes: incentive spirometry volume, bilateral diaphragmatic excursion via ultrasonography, pain scores (using the Numeric Rating Scale), and brachial plexus motor and sensory exams. Investigators will be blinded to whether the patient is in the intervention or treatment group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will have 30ml normal saline injected into their nerve catheter. The treatment group will have the following measured/ assessed after 10 minutes: incentive spirometry volume, bilateral diaphragmatic excursion via ultrasonography, pain scores (using the Numeric Rating Scale), and brachial plexus motor and sensory exams. Investigators will be blinded to whether the patient is in the intervention or treatment group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normal saline injected via interscalene nerve catheter</intervention_name>
    <description>With the catheter covered, treatment group patients will receive a normal saline (NS) bolus regimen (30cc 0.9% NS) via their interscalene nerve block catheter.</description>
    <arm_group_label>Treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>With the catheter covered, placebo group patients will go through the same steps as the treatment group, but no solution will be injected into the interscalene nerve block catheter.</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  All adult patients (18 years and over) scheduled for surgery requiring a continuous&#xD;
             interscalene brachial plexus nerve block catheter as part of their anesthetic care.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Concomitant life-threatening injuries and other concomitant injuries causing&#xD;
             significant pain&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Any condition impairing patient's ability to consent to participation in study, and an&#xD;
             existing condition contraindicating a nerve block, i.e. nerve injury, existing&#xD;
             bleeding disorder, infection in the vicinity of the block, and patient refusal.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ban Tsui, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford Health Care (SHC)</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Urmey WF, Talts KH, Sharrock NE. One hundred percent incidence of hemidiaphragmatic paresis associated with interscalene brachial plexus anesthesia as diagnosed by ultrasonography. Anesth Analg. 1991 Apr;72(4):498-503.</citation>
    <PMID>2006740</PMID>
  </reference>
  <reference>
    <citation>Urmey WF, McDonald M. Hemidiaphragmatic paresis during interscalene brachial plexus block: effects on pulmonary function and chest wall mechanics. Anesth Analg. 1992 Mar;74(3):352-7.</citation>
    <PMID>1539813</PMID>
  </reference>
  <reference>
    <citation>Lenters TR, Davies J, Matsen FA 3rd. The types and severity of complications associated with interscalene brachial plexus block anesthesia: local and national evidence. J Shoulder Elbow Surg. 2007 Jul-Aug;16(4):379-87. Epub 2007 Apr 19.</citation>
    <PMID>17448698</PMID>
  </reference>
  <reference>
    <citation>Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med. 2004 Jul-Aug;29(4):333-40. Review.</citation>
    <PMID>15305253</PMID>
  </reference>
  <reference>
    <citation>Katircioglu K, Ozkalkanli MY, Kalfaoglu H, Sannav S, Ozgurbuz U, Savaci S. Reversal of prilocaine epidural anesthesia using epidural saline or ringer's lactate washout. Reg Anesth Pain Med. 2007 Sep-Oct;32(5):389-92.</citation>
    <PMID>17961836</PMID>
  </reference>
  <reference>
    <citation>Park EY, Kil HK, Park WS, Lee NH, Hong JY. Effect of epidural saline washout on regression of sensory and motor block after epidural anaesthesia with 2% lidocaine and fentanyl in elderly patients. Anaesthesia. 2009 Mar;64(3):273-6. doi: 10.1111/j.1365-2044.2008.05746.x.</citation>
    <PMID>19302639</PMID>
  </reference>
  <reference>
    <citation>Sitzman BT, DiFazio CA, Playfair PA, Stevens RA, Hanes CF, Herman TB, Yates HK, Leisure GS. Reversal of lidocaine with epinephrine epidural anesthesia using epidural saline washout. Reg Anesth Pain Med. 2001 May-Jun;26(3):246-51.</citation>
    <PMID>11359224</PMID>
  </reference>
  <reference>
    <citation>Ip VH, Tsui BC. Continuous interscalene block: the good, the bad and the refined spread. Acta Anaesthesiol Scand. 2012 Apr;56(4):526-30. doi: 10.1111/j.1399-6576.2012.02650.x. Epub 2012 Feb 16.</citation>
    <PMID>22338616</PMID>
  </reference>
  <reference>
    <citation>Courtney KR, Kendig JJ, Cohen EN. Frequency-dependent conduction block: the role of nerve impulse pattern in local anesthetic potency. Anesthesiology. 1978 Feb;48(2):111-7.</citation>
    <PMID>306789</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 18, 2018</study_first_submitted>
  <study_first_submitted_qc>September 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2018</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Chi-Ho Ban Tsui</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Arm Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

